77 related articles for article (PubMed ID: 3334194)
1. Use of surfactant beyond respiratory distress syndrome, what is the evidence?
Desai RK; Yildiz Atar H; Lakshminrusimha S; Ryan RM
J Perinatol; 2024 Apr; 44(4):478-487. PubMed ID: 38459371
[TBL] [Abstract][Full Text] [Related]
2. More and earlier surfactant for preterm infants.
Hughes JL; McCall E; Alderdice F; Jenkins J;
Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F125-6. PubMed ID: 16492949
[TBL] [Abstract][Full Text] [Related]
3. Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome.
Walther FJ; Chan H; Smith JR; Tauber M; Waring AJ
Sci Rep; 2021 Aug; 11(1):16439. PubMed ID: 34385559
[TBL] [Abstract][Full Text] [Related]
4. Introduction to surfactant use in newborn infants.
van Kaam AH
Semin Fetal Neonatal Med; 2023 Dec; 28(6):101502. PubMed ID: 38030437
[No Abstract] [Full Text] [Related]
5. Lung ultrasound (LUS) and surfactant treatment: looking for the best predictive moment.
Kayki G; Yigit S; Tandircioglu UA; Celik HT; Yurdakok M
J Perinatol; 2021 Jul; 41(7):1669-1674. PubMed ID: 33758395
[TBL] [Abstract][Full Text] [Related]
6. Life-saving effect of pulmonary surfactant in premature babies.
Raj JU; Bland RD; Bhattacharya J; Rabinovitch M; Matthay MA
J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690742
[TBL] [Abstract][Full Text] [Related]
7. Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective.
Sivanandan S; Jain K; Plakkal N; Bahl M; Sahoo T; Mukherjee S; Gupta YK; Agarwal R
J Perinatol; 2019 Sep; 39(Suppl 1):20-30. PubMed ID: 31485015
[TBL] [Abstract][Full Text] [Related]
8. Evolution of mechanical ventilation of the newborn infant.
Mammel MC
Semin Perinatol; 2024 Mar; 48(2):151884. PubMed ID: 38555220
[TBL] [Abstract][Full Text] [Related]
9. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
Robertson B
Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
[TBL] [Abstract][Full Text] [Related]
10. [Substitutive therapy with surfactants in premature infants with respiratory distress syndrome].
Liberatore A; Carrera G; Calciolari G; Coccia C; Coppalini B; Fulconis F; Moro G; Scimone F; Villa G; Minoli I
Ann Osp Maria Vittoria Torino; 1987-1988; 30():28-35. PubMed ID: 3334194
[TBL] [Abstract][Full Text] [Related]
11. Exogenous lung surfactant: effect on radiographic appearance in premature infants.
Wood BP; Sinkin RA; Kendig JW; Notter RH; Shapiro DL
Radiology; 1987 Oct; 165(1):11-3. PubMed ID: 3306780
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
13. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
Ainsworth SB; Milligan DW
Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
[TBL] [Abstract][Full Text] [Related]
14. Replacement surfactant therapy.
Greenough A
Prof Care Mother Child; 1997; 7(4):99-100. PubMed ID: 9348968
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
